Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 25mg, 50mg, And 100mg Due to The Detection of Trace Amounts Of N-Nitroso N-Methyl 4-Amino Butyric Acid (NMBA) Impurity Found in The Active Pharmaceutical Ingredient (API)

0
29
Beef E. coli Outbreak investigation

Earth City, MO, Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg into the consumer level. This recall was prompted because of Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, as a result of detection of trace quantities of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a potential procedure impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API maker ).



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here